URSODEOXYCHOLIC ACID TREATMENT OF PRIMARY HEPATOLITHIASIS IN CAROLIS SYNDROME

Citation
E. Ros et al., URSODEOXYCHOLIC ACID TREATMENT OF PRIMARY HEPATOLITHIASIS IN CAROLIS SYNDROME, Lancet, 342(8868), 1993, pp. 404-406
Citations number
10
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
342
Issue
8868
Year of publication
1993
Pages
404 - 406
Database
ISI
SICI code
0140-6736(1993)342:8868<404:UATOPH>2.0.ZU;2-I
Abstract
Congenital cystic dilation of the intrahepatic bile ducts (Caroli's sy ndrome) is a rare cause of chronic cholestasis and hepatolithiasis in young adults. Long-term prognosis is poor even with surgical drainage. We treated twelve patients who had Caroli's syndrome and intrahepatic stones with ursodeoxycholic acid (UDCA), 10-20 mg/kg daily. The duode nal bile of these patients contained cholesterol crystals, which sugge sts that the stones were cholesterol rich. UDCA led to sustained clini cal remission, return to normal liver function, and dissolution of int rahepatic stones on ultrasound in all patients (nine partial, three co mplete) after 48 (range 12-114) months' follow-up. Litholytic therapy is indicated for intrahepatic stones in Caroli's syndrome.